Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience

Vaccine

Volumn 27, Issue 3, 2009, Pages 410-415

  Zuber, Patrick L F ^a   Dumolard, Laure ^a   Shirey, Meredith ^b   Rizzo, Ivone ^c   Marshall, John ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNICEF   (United States)

^c GAVI Alliance Secretariat   (Switzerland)

^d NONE

Author keywords

Demand forecast; Haemophilus influenzae; Vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; FORECASTING; HEALTH PROGRAM; PRIORITY JOURNAL; SOCIOECONOMICS;

BACTERIAL CAPSULES; DEVELOPING COUNTRIES; FORECASTING; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; VACCINATION;

EID: 57649219941     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.069     Document Type: Article

References (18)

1. GAVI Alliance [New and underused vaccine support]. Geneva: GAVI (Global Alliance for Vaccines and Immunization); c1999-2008 [cited 10 September 2008]. Available from: .
2. Rossi I.A., Zuber P.L.F., Dumolard L., Walker D.G., and Watt J. Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends. Vaccine 25 (2007, August) 7075-7080
3. World Health Organization. Review panel on Haemophilus influenzae type b (Hib) disease burden in Bangladesh, Indonesia and other Asian countries, Bangkok, 28-29 January 2004. Wkly Epidemiol Rec 79 (2004, April) 173-175
4. World Health Organization Regional Office for Africa, Vaccine Preventable Disease Unit. New vaccines introduction in the Africa Region: lessons learnt. Harare: WHO AFRO; 2008 [cited 10 September 2008]. Available from: .
5. Lee E.H., Lewis R.F., Makumbi I., Kekitiinwa A., Ediamu T.D., Bazibu M., et al. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Trop Med Int Health 13 (2008, April) 495-502
6. UNICEF [product menu for vaccines supplied by UNICEF for the global alliance for vaccines and immunization (GAVI)]. Copenhagen: UNICEF; 2008 [cited 10 September 2008]. Available from: .
7. Linstone H.A., and Turoff M. The Delphi method. Techniques and applications (1975), Addison-Wesley, Reading (MA)
8. WHO and UNICEF Joint Reporting Form: English. [Online]; 2008 [cited 10 September 2008]. Available from: .
9. World Health Organization. Procurement of vaccines for public sector programmes-a reference manual (WHO/V&B/03.16); 2003.
10. World Health Organization, UNICEF 2006. WHO-UNICEF guidelines for developing a comprehensive multi-year plan (cMYP) (WHO/IVB/05.20); 2006.
11. Miller M.A., and Flanders W.D. A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs. Vaccine 18 21 (2000, April) 2223-2230
12. GAVI Alliance [Application process]. Geneva: GAVI Alliance; 2008 [cited 10 September 2008]. Available from: .
13. Akumu A.O., English M., Scott J.A., and Griffiths U.K. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Org 85 7 (2007, July) 511-518
14. Ali S.S., Chandrashekar S.R., Singh M., Bansal R.K., Sharma D.R., and Arora D. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin 3 4 (2007 July-August) 116-120
15. World Health Organization. Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations Agencies. WHO/IVB/05.19; 2005.
16. Webby R., O'Conner M., and Lawrence. Judgmental time-series forecasting using domain knowledge. In: Armstrong J.S. (Ed). Principles of forecasting: a handbook for researchers and practitioners (2001), Springer, New York 389-405
17. Goodwin P. Integrating management judgment with statistical methods to improve short-term forecasts. Omega Int J Manage Sci 30 (2002) 127-135
18. Editor. The GAVI Alliance's new vaccine strategy. Lancet 2008 July; 372(9632):2.